Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Mark De Belder.
Newcastle Authors
Title
Year
Full text
Alastair Gray
Dr Mark De Belder
Professor Steve Jones
Christopher Malkin
Dr Andrew Owens
et al.
Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial
2022
Dr Mark De Belder
Professor Azfar Zaman
Survival relative to pacemaker status after transcatheter aortic valve implantation
2021
Professor Azfar Zaman
Dr Mark De Belder
Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysis
2020
Professor Azfar Zaman
Dr Mohaned Egred
Professor Thomas Johnson
Dr Mark De Belder
Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: The ABSORB UK Registry
2018
Dr Matthew Jackson
Dr David Austin
Muhammad Rashid
Dr Mark De Belder
Professor Azfar Zaman
et al.
The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society
2018
Dr Mark De Belder
Professor Azfar Zaman
Choice of Stent for Percutaneous Coronary Intervention of Saphenous Vein Grafts
2017
Dr Mark De Belder
Professor Azfar Zaman
The Relationship of Body Mass Index to Percutaneous Coronary Intervention Outcomes: Does the Obesity Paradox Exist in Contemporary Percutaneous Coronary Intervention Cohorts? Insights From the British Cardiovascular Intervention Society Registry
2017
Dr Mark De Belder
Professor Azfar Zaman
Changes in Arterial Access Site and Association With Mortality in the United Kingdom: Observations From a National Percutaneous Coronary Intervention Database
2016
Dr Mark De Belder
Professor Azfar Zaman
Outcomes Following Primary Percutaneous Coronary Intervention in Patients With Previous Coronary Artery Bypass Surgery
2016
Dr Andrew Turley
Dr James Hall
Dr Neil Swanson
Professor Rudy Bilous
Dr Mark De Belder
et al.
The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary intervention
2016
Professor Vijay Kunadian
Professor Azfar Zaman
Dr Mark De Belder
Effect of access site, gender, and indication on clinical outcomes after percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society (BCIS)
2015
Professor Bernard Keavney
Professor Azfar Zaman
Dr Mark De Belder
Impact of age on access site-related outcomes in 469,983 percutaneous coronary intervention procedures: Insights from the British Cardiovascular Intervention Society
2015
Professor Bernard Keavney
Professor Azfar Zaman
Dr Mark De Belder
Impact of Age on the Prognostic Value of Left Ventricular Function in Relation to Procedural Outcomes Following Percutaneous Coronary Intervention: Insights From the British Cardiovascular Intervention Society
2015
Professor Azfar Zaman
Professor Bernard Keavney
Dr Mark De Belder
Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12
2015
Professor Bernard Keavney
Professor Azfar Zaman
Dr Mark De Belder
Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society
2014
Professor Gerard Stansby
Dr Mark De Belder
Professor John Dark
Professor Gary Ford
Asymptomatic carotid disease and cardiac surgery consensus
2011
Professor Vijay Kunadian
Dr Neil Swanson
Dr Mark De Belder
Percutaneous coronary intervention using radial access is associated with less radiation exposure to patients compared with femoral access
2011
Professor Vijay Kunadian
Claire Chapple
Dr James Hall
Dr Mark De Belder
Cardiac catheterisation: radiation doses and lifetime risk of malignancy
2007
Professor Vijay Kunadian
Dr Janine Gray
Dr James Hall
Dr Alun Harcombe
Professor Jeremy Murphy
et al.
Early invasive versus conservative treatment in patients with failed fibrinolysis-no late survival benefit: The final analysis of the Middlesbrough Early Revascularisation to Limit Infarction (MERLIN) randomized trial
2007
Dr Janine Gray
Dr James Hall
Dr Alun Harcombe
Professor Jeremy Murphy
Dr Ananthaiah Shyam-Sundar
et al.
One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trial
2005
Dr Philip Campbell
Dr Janine Gray
Dr James Hall
Dr Alun Harcombe
Amy Wright
et al.
A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: The Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial
2004
Jean Gray
Dr Alun Harcombe
Dr James Hall
Dr Mark De Belder
The Middlesbrough early revascularisation to limit INfarction (MERLIN) trial: A randomised trial of rescue angioplasty versus medical treatment for failed fibrinolyis
2003
Dr James Hall
Dr Alun Harcombe
Dr Mark De Belder
Thrombocytopenia after abciximab use during percutaneous coronary intervention
2003
Dr Janet McComb
Dr Mark De Belder
Erosion of the left ventricle by the epicardial patch of an automatic implantable cardioverter defibrillator
1999